Aibili Logo Association for Innovation and Biomedical Research on Light

Latest Ongoing Projects


Coimbra Coordinating Centre for Clinical Research

Characterization of Retinal vascular disease in eyes with mild to moderate NPDR in Diabetes type 2, using novel non-invasive Imaging methods, in a longitudinal and prospective clinical Study with 2 years of duration. (CORDIS, Protocol CEC010/2018) [more info]

Progression of Diabetic Retinopathy. Identification of Signs and Surrogate outcomes. (PROGRESS, Protocol CEC/007/16) [more info]

Characterization of potential biomarkers of Eye Disease and Vision Loss (EyeMarker). [more info]

Centre for Clinical Trials

E3 Consortium to promote and sustain collaboration and sharing of data and knowledge in the field of ophthalmic epidemiology in Europe. E3 [more info]

A single arm, open-label, multicenter study evaluating the long-term safety and tolerability of 0.5mg fingolimod (FTY720) administered orally once daily in patients with relapsing forms of multiple sclerosis (Protocol CTFY720D2399) [more info]

Randomized, open label multi-center study comparing cabazitaxel at 25 mg/m2 in combination with prednisone every 3 weeks to Docexatel in combination with prednisone in patients with metastatic castration resistant prostate cancer not pre-treated with chemotherapy (Firstana) (Protocol EFC11784) [more info]

Centre of New Technologies for Medicine

Area of retinal layers disruption calculation tool [more info]

C-Tracer OCT Automatic Segmentation [more info]

FILTER – Framework to Develop and Validate Automated Image Analysis Systems for Early Diagnosis and Treatment of Eyes at Risk in Blinding Age-Related Disease [more info]

Coimbra Ophthalmology Reading Centre

Framework to Develop and Validate Automated Image Analysis Systems for Early Diagnosis and Treatment of Eyes at Risk in Blinding Age-Related Diseases. (FILTER) [more info]

Characterization of Retinal vascular disease in eyes with mild to moderate NPDR in Diabetes type 2, using novel non-invasive Imaging methods, in a longitudinal and prospective clinical Study with 2 years of duration. (CORDIS, Protocol CEC010/2018) [more info]

A Phase 2, randomised, single-masked, active-controlled, multicentre study to evaluate the efficacy and safety of intravitreal THR-317 when administered alone or in combination with Lucentis®, in diabetic macular oedema (DME) patients with a poor or no response to anti vascular endothelial growth factor (anti-VEGF) treatment. (Protocol THR-317-002) [more info]

Centre for Health Technology Assessment and Drug Research

Budget impact analysis of Kalydeco [more info]

Evaluation of the therapeutic value of Alecensa [more info]

Evaluation of the therapeutic value of Parsabiv [more info]

Pharmacovigilance Unit of Coimbra

Unidade de farmacovigilância de coimbra [more info]

Data Centre

eCRF Design and Development, IT support and Training and Long Term Data Storage Services for GS030 Study [more info]

eCRF Design and Development, IT support and Training and Long Term Data Storage Services for MADEOS Study [more info]

Ongoing IT Support, Data Storage and Long Term Data Storage Services for PROGRESS Study [more info]

Projects by department:

  -   Cloud   -  Copyright © AIBILI   -   Contact Us   -   Site Map   -   Privacy Policy  -  Cookies Policy  -  Webdesign Glitz Design   -   Programming Bizview